Fundraising Fox

Kura Oncology

NASDAQ: KURA

La Jolla, US · Founded 2014 · Delaware corporation · 6 known investors

kuraoncology.com ↗

Kura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.

BiotechDigital HealthMedical Devices

Founders & leadership

HH
HEIDI HENSONExecutive Officer
TW
TROY WILSONExecutive Officer, Director
AN
ANNETTE NORTHExecutive Officer
PR
PINGDA RENExecutive Officer
YL
YI LIUExecutive Officer
AG
ANTONIO GUALBERTOExecutive Officer

Investors · 6

ARCH Venture PartnersChicago · $50K – $250M
Avoro Capital AdvisorsNew York
EcoR1 CapitalSan Francisco
Foresite CapitalLarkspur
Nextech InvestZurich · $648K – $3.2M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$150MraisedFeb 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DIANE PARKSDirector
  • TERESA BAIRExecutive Officer
  • FAHEEM HASNAINDirector
  • HELEN COLLINSDirector
  • BRIAN POWLExecutive Officer
  • THOMAS MALLEYDirector
  • MARY SZELADirector
  • KATHLEEN FORDExecutive Officer
  • CAROL SCHAFERDirector
  • TROY WILSONExecutive Officer, Director
  • STEPHEN DALEExecutive Officer
Offering amount
$150M
Amount sold
$150M
Sales commissions
$3.8M
Placement agents
Leerink Partners LLC
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60.4MraisedMar 2015 · 337 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PINGDA RENExecutive Officer
  • ANTONIO GUALBERTOExecutive Officer
  • ANNETTE NORTHExecutive Officer
  • HEIDI HENSONExecutive Officer
  • YI LIUExecutive Officer
  • TROY WILSONExecutive Officer, Director
Offering amount
$60.4M
Amount sold
$60.4M
Finders' fees
$3.1M
Placement agents
National Securities Corporation, Leerink Partners LLC, Livingston Securities LLC
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$91.7MraisedMar 2015 · 356 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ANNETTE NORTHExecutive Officer
  • TROY WILSONExecutive Officer, Director
  • PINGDA RENExecutive Officer
  • YI LIUExecutive Officer
  • ANTONIO GUALBERTOExecutive Officer
  • HEIDI HENSONExecutive Officer
Offering amount
$91.7M
Amount sold
$91.7M
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJan 2015 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • HEIDI HENSONExecutive Officer
  • TROY WILSONExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
First sale
Jan 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news